Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Olanzapine to reduce chemotherapy-induced nausea and vomiting in children
IRCT20090613002027N14Phase 3Completed
- Sponsor
- Mazandaran University of Medical Sciences
- Start
- Jan 2018
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3 trial of olanzapine in chemotherapy-induced nausea and vomiting (CINV), sponsored by Mazandaran University of Medical Sciences. Started Jan 2018; status: completed.
02
Drugs
olanzapine
03
Conditions
chemotherapy-induced nausea and vomiting (CINV)
Beyond the preview
Go deeper on IRCT20090613002027N14.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on IRCT20090613002027N14.